MONTREAL, QUEBEC--(CCNMatthews - March 15, 2007) - IBEX Technologies Inc. (TSX:IBT), an innovator in the development of diagnostics for the management of cancer and arthritis, and a supplier of high-purity glycobiology enzymes, today reported its financial results for the three and six-month periods ended January 31, 2007.
